8/19/2025RemeGen and Santen Enter into Licensing Deal for Ophthalmic Drug RC28-...

8/19/2025BioNTech's BNT327 Shows Strong Phase II Results as China-Originated Dr...

8/19/2025CANbridge Announces Strategic Partnership and Investment from Baheal 

8/18/2025Pleryon Completes First Closing of Series A Financing

8/18/2025Yixuan Secures Angel Financing to Advance Novel Nucleic Acid Drug Deve...

8/18/2025Aoda Raises CNY30M Series A to Advance Dual-Receptor Agonist Program

8/18/2025Latticon Completes Series A Financing to Advance Trial of LAT010 Immun...

8/18/2025Tarlatamab Shows Promising Results in Chinese Phase 2 Trial for Heavil...

8/15/2025NHSA Issues Interim Measures for Disease-Based Medical Insurance Payme...

8/15/2025Guangzhou Innogen Pharma Debuts on HKSE Amid Expanding Metabolic Pipel...

8/14/2025CDE Seeks Public Input on Draft Guidelines for Bayesian Methods in Cli...

8/14/2025CDE Issues New Technical Guidelines for Clinical Development of Osteoa...

8/14/2025CDE Solicits Comments on Draft ICH M4Q(R2) Guidelines for Drug Qualit...

8/14/2025CDE Seeks Public Input on Draft Guidelines for Rare Disease Drug Devel...

8/14/2025Remegen's Telitacicept Achieves Phase III Success

8/14/2025CTTQ Unveils Promising Phase 2 Data for HER2 Bispecific ADC TQB2102

8/14/2025YolTech Unveils Breakthru In Vivo Editing of Human Blood Stem Cells

8/14/2025GenFleet's GFH375 KRAS G12D Inhibitor Delivers Strong NSCLC Data

8/14/2025Qihan Earns FDA Green Light for Pioneering Dual-Target CAR-T Therapy i...

8/14/2025Innovent's U.S. Unit Fortvita Launches Phase 1 Trial of Oral GLP-1 Ago...

8/14/2025Amphastar Strikes Major Licensing Deal to Supercharge Peptide Pipeline

8/14/2025ArkBio's Ziresovir Included into Pediatric RSV Drug Priority List by W...

8/13/2025MNCs Target China's New Commercial Insurance Catalog to Gain Ground

8/13/2025Summit Skips Quarterly Earnings Call amid Strategic Shifts and BLA Pla...

8/13/2025Gracell Gains NMPA Approval to Advance GC012F into Light-Chain Amyloid...

8/13/2025NHSA Publishes Preliminary Review Results for 2025 NRDL Adjustments wi...

8/13/2025CTTQ Secures IND Acceptance from China's NMPA for Two Innovative Cance...

8/13/2025Haichang Biotech Completes Nearly CNY 500M Series C Financing to Advan...

8/13/2025Merck Halts NSCLC Development of MK-1308 Amid Partnership with China's...

8/12/2025Akeso Doses First Patient in Phase III Trial of Ivonescimab

Page:20/58 Total number of articles:1732: [First][<<] [18] [19] [20] [21] [22] [>>] [End]